Last 12 months
Inside the activity.
1 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 1 | 11 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2024 Filed May 16, 2024 16:30 UTC |
Vig PamelaCHIEF SCIENTIFIC OFFICER
|
GrantCommon Stock | 94 | $21.05 | $1,978.32 |
DisclosureSEC source: 0001415889-24-013354 · form4-05162024_040526.xml · nonDerivative · entry 1 Vig Pamela · CIK 0001780069 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,406 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 94 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2024 Filed May 16, 2024 20:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 817 | $21.05 | $17,194.58 |
DisclosureSEC source: 0001415889-24-013355 · form4-05162024_040530.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,770 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 817 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 10, 2024 Filed May 16, 2024 20:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 470 | $21.05 | $9,891.62 |
DisclosureSEC source: 0001415889-24-013356 · form4-05162024_040533.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,470 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 470 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 00:47 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 2,000 | $24.80 | $49,600.00 |
DisclosureSEC source: 0001415889-24-009280 · form4-03282024_120312.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Read SEC document |
| March 25, 2024 Filed Mar 25, 2024 21:41 UTC |
Radovich PeterPRESIDENT AND COO
|
SaleCommon Stock | 4,303 | $25.80 | $111,017.40 |
DisclosureSEC source: 0001415889-24-009046 · form4-03252024_090335.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,013 F1 · price: The weighted average sale price for the transaction reported was $25.80, and the range of prices were between $25.80 and $25.825. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 18, 2024 Filed Mar 18, 2024 21:34 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 2,000 | $25.80 | $51,600.00 |
DisclosureSEC source: 0001415889-24-008311 · form4-03182024_090313.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| February 02, 2024 Filed Feb 3, 2024 02:28 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 735 | $26.19 | $19,250.97 |
DisclosureSEC source: 0001415889-24-002412 · form4-02032024_020214.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,759 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 21:12 UTC |
Vig PamelaCHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 1,214 | $26.19 | $31,796.85 |
DisclosureSEC source: 0001415889-24-002757 · form4-02062024_020209.xml · nonDerivative · entry 1 Vig Pamela · CIK 0001780069 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,691 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 02:10 UTC |
Longpre LaraCHIEF DEVELOPMENT OFFICER
|
SaleCommon Stock | 847 | $26.19 | $22,184.45 |
DisclosureSEC source: 0001415889-24-002756 · form4-02062024_020236.xml · nonDerivative · entry 1 Longpre Lara · CIK 0001780347 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,407 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 02:05 UTC |
Radovich PeterPRESIDENT AND COO
|
SaleCommon Stock | 1,790 | $26.19 | $46,883.14 |
DisclosureSEC source: 0001415889-24-002755 · form4-02062024_020222.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,695 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 02:04 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 6,013 | $26.19 | $157,491.29 |
DisclosureSEC source: 0001415889-24-002754 · form4-02062024_020203.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,112 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:28 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002412 · form4-02032024_020214.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,543 Underlying: Common Stock · 1,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares will vest January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares will vest January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:28 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionCommon Stock | 1,772 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002412 · form4-02032024_020214.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
GrantRestricted Stock Units · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001827 · form4-01252024_070108.xml · derivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001827 · form4-01252024_070108.xml · derivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 19:10 UTC |
Vig PamelaCHIEF SCIENTIFIC OFFICER
|
GrantRestricted Stock Units · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001826 · form4-01252024_070108.xml · derivative · entry 2 Vig Pamela · CIK 0001780069 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 19:10 UTC |
Vig PamelaCHIEF SCIENTIFIC OFFICER
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001826 · form4-01252024_070108.xml · derivative · entry 1 Vig Pamela · CIK 0001780069 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Longpre LaraCHIEF DEVELOPMENT OFFICER
|
GrantRestricted Stock Units · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001825 · form4-01252024_070106.xml · derivative · entry 2 Longpre Lara · CIK 0001780347 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Longpre LaraCHIEF DEVELOPMENT OFFICER
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001825 · form4-01252024_070106.xml · derivative · entry 1 Longpre Lara · CIK 0001780347 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001824 · form4-01252024_070104.xml · derivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001824 · form4-01252024_070104.xml · derivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Radovich PeterPRESIDENT AND COO
|
GrantRestricted Stock Units · Derivative | 17,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001823 · form4-01252024_070101.xml · derivative · entry 2 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,250 Underlying: Common Stock · 17,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Radovich PeterPRESIDENT AND COO
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001823 · form4-01252024_070101.xml · derivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001822 · form4-01252024_070102.xml · derivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001822 · form4-01252024_070102.xml · derivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 00:42 UTC |
Quan JoanneCHIEF MEDICAL OFFICER
|
GrantRestricted Stock Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001561 · form4-01192024_120106.xml · derivative · entry 2 Quan Joanne · CIK 0001670138 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 00:42 UTC |
Quan JoanneCHIEF MEDICAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $26.72 | $0.00 |
DisclosureSEC source: 0001415889-24-001561 · form4-01192024_120106.xml · derivative · entry 1 Quan Joanne · CIK 0001670138 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-01-15 F1 · derivative.exercise_date: 1/4th of the shares subject to the option will vest one year after January 16, 2024 (the "Vesting Commencement Date") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 01:09 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 528 | $28.04 | $14,802.53 |
DisclosureSEC source: 0001415889-24-000880 · form4-01102024_010137.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 20:21 UTC |
Vig PamelaHEAD OF RESEARCH & DEVELOPMENT
|
SaleCommon Stock | 1,408 | $28.03 | $39,472.29 |
DisclosureSEC source: 0001415889-24-000882 · form4-01102024_010110.xml · nonDerivative · entry 1 Vig Pamela · CIK 0001780069 · HEAD OF RESEARCH & DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,905 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 01:28 UTC |
Radovich PeterCHIEF OPERATING OFFICER
|
SaleCommon Stock | 1,408 | $28.03 | $39,472.58 |
DisclosureSEC source: 0001415889-24-000884 · form4-01102024_010106.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,485 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 01:25 UTC |
Longpre LaraCHIEF DEVELOPMENT OFFICER
|
SaleCommon Stock | 1,019 | $28.04 | $28,567.67 |
DisclosureSEC source: 0001415889-24-000883 · form4-01102024_010122.xml · nonDerivative · entry 1 Longpre Lara · CIK 0001780347 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,254 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 01:12 UTC |
Peetz ChristopherDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 5,209 | $28.03 | $146,033.27 |
DisclosureSEC source: 0001415889-24-000881 · form4-01102024_010133.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,125 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 06, 2024 Filed Jan 10, 2024 01:09 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000880 · form4-01102024_010137.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025. Read SEC document |
| January 06, 2024 Filed Jan 10, 2024 01:09 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-000880 · form4-01102024_010137.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 22:16 UTC |
Howe JolandaSVP, Global Controller
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001209191-23-057650 · doc4.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,400 Underlying: Common Stock · 2,500 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 22:16 UTC |
Howe JolandaSVP, Global Controller
|
SaleCommon Stock | 2,500 | $32.40 | $81,000.00 |
DisclosureSEC source: 0001209191-23-057650 · doc4.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 22:16 UTC |
Howe JolandaSVP, Global Controller
|
Exercise / conversionCommon Stock | 2,500 | $2.94 | $7,350.00 |
DisclosureSEC source: 0001209191-23-057650 · doc4.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 20:14 UTC |
Vig PamelaHead of Research & Development
|
GrantCommon Stock | 527 | $22.29 | $11,745.25 |
DisclosureSEC source: 0001209191-23-055436 · doc4.xml · nonDerivative · entry 1 Vig Pamela · CIK 0001780069 · Head of Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,313 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 527 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2023 Filed Nov 16, 2023 01:13 UTC |
Longpre LaraChief Development Officer
|
GrantCommon Stock | 434 | $22.29 | $9,672.56 |
DisclosureSEC source: 0001209191-23-055434 · doc4.xml · nonDerivative · entry 1 Longpre Lara · CIK 0001780347 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,273 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 434 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2023 Filed Nov 16, 2023 01:11 UTC |
Radovich PeterChief Operating Officer
|
GrantCommon Stock | 218 | $22.29 | $4,858.57 |
DisclosureSEC source: 0001209191-23-055433 · doc4.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,893 F1 · kind: This Form 4 is being filed voluntarily to report the acquisition of 218 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 09, 2023 Filed Nov 14, 2023 21:35 UTC |
Heron Patrick JDirector
|
PurchaseCommon Stock | 2,910 | $28.30 | $82,353.00 |
DisclosureSEC source: 0001209191-23-055180 · doc4.xml · nonDerivative · entry 1 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Frazier Life Sciences X, L.P. Disclosed balance after: 161,963 F1 · ownership.nature: The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person and James N. Topper are the managing members of FHMLS X, L.L.C. and share voting and dispositive power over the shares held by Frazier Life Sciences X, L.P. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2023 Filed Sep 14, 2023 23:33 UTC |
GREY MICHAEL GDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,216 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001209191-23-049511 · doc4.xml · derivative · entry 8 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,176 Underlying: Common Stock · 14,216 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the shares vest one year after November 5, 2018, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase. Read SEC document |
| September 14, 2023 Filed Sep 14, 2023 23:33 UTC |
GREY MICHAEL GDirector
|
SaleCommon Stock | 14,216 | $32.00 | $454,912.00 |
DisclosureSEC source: 0001209191-23-049511 · doc4.xml · nonDerivative · entry 4 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 30, 2022. Read SEC document |
| September 14, 2023 Filed Sep 14, 2023 23:33 UTC |
GREY MICHAEL GDirector
|
Exercise / conversionCommon Stock | 14,216 | $2.94 | $41,738.18 |
DisclosureSEC source: 0001209191-23-049511 · doc4.xml · nonDerivative · entry 3 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 23:33 UTC |
GREY MICHAEL GDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 392 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001209191-23-049511 · doc4.xml · derivative · entry 7 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,392 Underlying: Common Stock · 392 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the shares vest one year after November 5, 2018, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 23:33 UTC |
GREY MICHAEL GDirector
|
SaleCommon Stock | 392 | $32.00 | $12,544.00 |
DisclosureSEC source: 0001209191-23-049511 · doc4.xml · nonDerivative · entry 2 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 30, 2022. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 23:33 UTC |
GREY MICHAEL GDirector
|
Exercise / conversionCommon Stock | 392 | $2.94 | $1,150.91 |
DisclosureSEC source: 0001209191-23-049511 · doc4.xml · nonDerivative · entry 1 GREY MICHAEL G · CIK 0001240122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 20:56 UTC |
Heron Patrick JDirector
|
PurchaseCommon Stock | 2,625 | $31.02 | $81,424.88 |
DisclosureSEC source: 0001209191-23-049614 · doc4.xml · nonDerivative · entry 1 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Frazier Life Sciences X, L.P. Disclosed balance after: 159,053 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.9633 to $31.0499, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. F2 · ownership.nature: The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person and James N. Topper are the managing members of FHMLS X, L.L.C. and share voting and dispositive power over the shares held by Frazier Life Sciences X, L.P. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 20:39 UTC |
Heron Patrick JDirector
|
PurchaseCommon Stock | 3,750 | $30.60 | $114,763.88 |
DisclosureSEC source: 0001209191-23-049292 · doc4.xml · nonDerivative · entry 2 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Frazier Life Sciences X, L.P. Disclosed balance after: 156,428 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.2781 to $30.7970, inclusive. F2 · ownership.nature: The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person and James N. Topper are the managing members of FHMLS X, L.L.C. and share voting and dispositive power over the shares held by Frazier Life Sciences X, L.P. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein. Read SEC document |
| September 11, 2023 Filed Sep 12, 2023 22:23 UTC |
BJERKHOLT ERICChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049133 · doc4.xml · derivative · entry 3 BJERKHOLT ERIC · CIK 0001197350 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023. F4 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning on the one year anniversary of September 11, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.